Indeed miR-181b in-vitro overexpression reduced IGF-1R expression levels; in glioma clinical specimens, an inverse correlation between miR-181b and IGF-1R has been observed thus confirming the in-vitro results [147]. Here, IGF1R is linked to glioma.